Silence Therapeutics plc (SLN)
NASDAQ·Healthcare·Biotechnology
$19.75
-0.18%
Mkt Cap $292.38M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$57.00
Range $49.00 – $67.00
Implied Upside
+188.7%
Consensus $57.00 vs current $19.75
NASDAQ·Healthcare·Biotechnology
$19.75
-0.18%
Mkt Cap $292.38M
No recent rating data.
Price Target (5 analysts)
$57.00
Range $49.00 – $67.00
+188.7%
Consensus $57.00 vs current $19.75